510(k) · Cleared
ClearedBayer Immuno 1 Her-2/Neu Assay
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Bayer Corp. · NCW System, Test, Her-2/Neu, Monitoring
Cleared on Sep 29, 2000 after a 455-day review. The FDA summary names no predicate by number. 1 later device descends from it.
- Decided
- Sep 29, 2000
- Review
- 455 days
- Class
- Class II
- Product code
- NCW
- Recalls
- None
- Predicates
- 0
1 later device descends from it, 1 citing it directly.
- This deviceK992228 Bayer Immuno 1 Her-2/Neu AssayBayer Corp. · 2000
- Descendant · cites it directly · 0 of its ownK024017 Bayer Advia Centaur Her-2/Neu AssayBayer Corp. · 2003 · Recalled
Most influential descendants
Showing 1 of 1 · See all- K024017Bayer Advia Centaur Her-2/Neu AssayBayer Corp. · 2003 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K992228 | Bayer Immuno 1 Her-2/Neu Assay | Bayer Corp. | 2000 | — |
| +1 | K024017 | Bayer Advia Centaur Her-2/Neu Assay | Bayer Corp. | 2003 | 1 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2003 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NCW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against?
The FDA summary names no predicate by number.
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K024017 | Bayer Advia Centaur Her-2/Neu Assay | 2003 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K024017 (Bayer Corp., 2003) has gone furthest, with 0 descendants of its own.
How does its category compare?
All NCW devicesNCW System, Test, Her-2/Neu, Monitoring: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · NCW
FDA has decided no NCW device since 2007.
Median 510(k) review, days · NCW
Too few NCW 510(k)s in any year since 2007 to give a median.
Recalls per year · NCW
1in 2020
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · NCW
No MAUDE report names NCW since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 1 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Bayer Immuno 1™ Her-2/neu Assay is an in vitro, diagnostic device intended for use in the quantitative determination of HER-2/neu in human serum. HER-2/neu values obtained may be used in the follow-up and monitoring of patients with metastatic breast cancer. HER-2/neu values should be used in conjunction with information available from clinical and other diagnostic procedures in the management of breast cancer. The clinical utility of the serum measurement of HER-2/neu as a prognostic indicator for early recurrence and in the management of patients on immunotherapy regimens has not been fully established.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K992228 · printed Nov 6, 2026
Cite this page
510(k) Report. “K992228: Bayer Immuno 1 Her-2/Neu Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K992228
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026